Concepts (42)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophage Activation | 1 | 2026 | 33 | 0.970 |
Why?
|
| Macrophages | 1 | 2026 | 308 | 0.790 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 55 | 0.700 |
Why?
|
| Influenza, Human | 1 | 2022 | 101 | 0.660 |
Why?
|
| Cisplatin | 1 | 2020 | 186 | 0.600 |
Why?
|
| Peptides | 3 | 2022 | 297 | 0.600 |
Why?
|
| Paclitaxel | 1 | 2020 | 201 | 0.600 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 686 | 0.440 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 610 | 0.420 |
Why?
|
| Animals | 5 | 2026 | 10802 | 0.230 |
Why?
|
| Immunity, Innate | 1 | 2026 | 234 | 0.200 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2022 | 9 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 68 | 0.180 |
Why?
|
| Humans | 6 | 2026 | 29202 | 0.180 |
Why?
|
| Nanomedicine | 2 | 2019 | 62 | 0.180 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 81 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 1 | 2022 | 278 | 0.170 |
Why?
|
| Cartilage, Articular | 1 | 2021 | 44 | 0.170 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 89 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 53 | 0.160 |
Why?
|
| Biocompatible Materials | 2 | 2021 | 95 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 314 | 0.160 |
Why?
|
| Signal Transduction | 1 | 2026 | 1502 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 172 | 0.150 |
Why?
|
| Cell Movement | 1 | 2020 | 378 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 472 | 0.130 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 17 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 63 | 0.120 |
Why?
|
| Nanostructures | 1 | 2016 | 64 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2019 | 292 | 0.110 |
Why?
|
| Mice | 1 | 2022 | 4867 | 0.090 |
Why?
|
| Female | 1 | 2020 | 15819 | 0.050 |
Why?
|
| Chondrogenesis | 1 | 2021 | 29 | 0.040 |
Why?
|
| Regeneration | 1 | 2021 | 77 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2021 | 152 | 0.040 |
Why?
|
| Editorial Policies | 1 | 2019 | 7 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 53 | 0.040 |
Why?
|
| Research | 1 | 2019 | 93 | 0.040 |
Why?
|
| Biological Transport | 1 | 2019 | 128 | 0.040 |
Why?
|
| Endocytosis | 1 | 2019 | 97 | 0.040 |
Why?
|
| Kinetics | 1 | 2019 | 553 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 794 | 0.030 |
Why?
|